Article Name Clinical & Diagnostic
Escala Medical Ltd., proudly announces its selection as a recipient of a €5.5 million in grant and equity investment from the European Innovation Council. Escala is at the forefront of the pelvic organ prolapse (POP) treatment revolution.
26th June, 2023
Medtronic plc(opens new window) (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting glycemic goals, and individuals using a simplified meal announcement leveraging fixed carbohydrate amounts instead of exact carb calculations, found that the proprietary Meal Detection™ technology supported Time in Range outcomes that exceed consensus guidelines of 70 percent. Additionally, the system is helping reduce the percent of time spent in hyperglycemia in children and adults.
26th June, 2023
Patient made successful recovered after five days on ECMO
26th June, 2023
The machine is set up at a cost of Rs 12 crore
26th June, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer